• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES Back to Search Results
Model Number PVS23
Device Problems Inadequacy of Device Shape and/or Size (1583); Unintended Movement (3026)
Patient Problems Aortic Regurgitation (1716); No Information (3190)
Event Date 05/06/2019
Event Type  Injury  
Manufacturer Narrative
Device location not presently known.
 
Event Description
On (b)(6) 2019, a male patient received a pvs23 in aortic position.On (b)(6) 2019, the pvs23 was explanted and replaced with a pvs25.No other information is presently available.
 
Manufacturer Narrative
Based on the additional information received, the explant of the device was attributed to a non-structural dysfunction of the device, which appears to be 'rocking' in the aortic root.Since the device was not returned to the manufacturer, no device inspection can be performed at this time.However, given that a bigger size (i.E.Pvs25) was reportedly implanted, it is possible that the device was initially undersized thus contributing to the reported event.The manufacturer was informed on this event through the device tracking department.There has been no allegation of device malfunction or complaint by the site.If additional information will become available, a follow up report will be submitted.
 
Event Description
On (b)(6) 2019, a male patient received a pvs23 in aortic position.On (b)(6) 2019, the pvs23 was explanted and replaced with a pvs25.Per additional information received from the site, the implant of the pvs23 was completed successfully on (b)(6) 2019.The post-operative echo revealed a well-seated prosthesis, with no evidence of a paravalvular leak or intravalvular leaks.The gradient across the valve measure 16mmhg peak and 7mmhg mean.However, in the cardiac test performed on (b)(6) 2019, the valve was noted to be rocking within the aortic root.The valve leaflets are thickened and poorly visualized.There is at least moderate aortic valve regurgitation; the perivalvular leak is not confirmed due to the limiting quality of the study.A re-intervention occurred on (b)(6) 2019, in which the pvs23 was explanted and the pvs25 was implanted.The post-operative echo revealed a well-seated valve; there is a perivalvular leak noted with moderate insufficiency, and a mean gradient of 10mmhg.
 
Manufacturer Narrative
The manufacturing and material records for the perceval heart valve, model#: icv1209, s/n#: (b)(6), as they pertain to the reported event, were retrieved and reviewed by quality engineering at livanova canada corp.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model#: icv1209) perceval heart valve at the time of manufacture and release.Based on the review performed, no manufacturing deficits were identified.Based on the available information, given that a bigger size (i.E.Pvs25) was implanted after one week, it is possible that the device was initially undersized thus contributing to the reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVES
Manufacturer (Section D)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, british columbia
MDR Report Key9182062
MDR Text Key162487170
Report Number3004478276-2019-00277
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)210208
Combination Product (y/n)N
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 01/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/11/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/08/2021
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was the Report Sent to FDA? No
Date Manufacturer Received01/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
-
-